中华糖尿病杂志
中華糖尿病雜誌
중화당뇨병잡지
CHINES JOURNAL OF DLABETES MELLITUS
2009年
6期
427-432
,共6页
刘逸超%李威%王秀秀%丛晶%侯丽辉%吴效科
劉逸超%李威%王秀秀%叢晶%侯麗輝%吳效科
류일초%리위%왕수수%총정%후려휘%오효과
隐丹参酮%卵巢器官培养%胰岛素抵抗%雄激素
隱丹參酮%卵巢器官培養%胰島素牴抗%雄激素
은단삼동%란소기관배양%이도소저항%웅격소
Cryptotanshinone%Ovary culture%Insulin resistance%Androgen
目的 通过地塞米松体外诱导卵巢器宫胰岛素抵抗,探讨隐丹参酮对糖代谢、激素以及卵巢信号分子的影响.方法 40只18 g清洁级昆明白雌性小鼠进行卵巢器官体外培养,加入300 nmol/L地塞米松持续干预48 h,取2组加入隐丹参酮和曲格列酮干预48 h,检测卵巢应用培养液葡萄糖变化情况,利用RT-PCR技术检测AKT2、CSK3β、ERK、MCN2、CYP17、CYP19、AMH基因表达水平.采用t检验进行统计学分析.结果 地塞米松诱导48 h后培养液葡萄糖利用下降,睾酮[分别为(1.85±0.81)、(0.13±0.12)nmol/L,t=4.21,P=0.006]、雄烯二酮[分别为(6.44±0.69)、(0.24±0.15)μg/L,t=-5.11,P=0.002]升高,而孕酮[分别为(14.64±0.68)、(79.38±3.87)nmol/L,t=5.96,P=0.001]、17-羟孕酮[分别为(0.18±0.09)、(0.44±0.06)μg/L,t=3.408,P=0.014]下降.AKT2、GSK3β、ERK mRNA表达下调,MCM2、CYP17表达上调,AMH各组无表达.隐丹参酮干预后,处理组葡萄糖利用升高,睾酮[分别为(0.78±0.23)、(1.85±0.81)nmol/L,t=-2.547,P=0.044]、雄烯二酮[分别为(4.07±0.50)、(6.44±0.69)μg/L,t=4.019,P=0.009]、孕酮[分别为(2.97±1.02)、(14.64±0.68)nmol/L,t=5.959,P=0.001]明显下降,17-羟孕酮[分别为(0.40±0.08)、(0.18±0.09)μg/L,t=-3.113,P=0.036]升高,信号分子表达明显改善.曲格列酮干预结果与之相似,仅孕酮和17-羟孕酮水平变化相反.结论 地塞米松诱导卵巢造成胰岛素抵抗,卵巢增殖功能异常,雄激素合成亢进.隐丹参酮对糖代谢、细胞增殖、激素合成的信号分子具有调控作用.
目的 通過地塞米鬆體外誘導卵巢器宮胰島素牴抗,探討隱丹參酮對糖代謝、激素以及卵巢信號分子的影響.方法 40隻18 g清潔級昆明白雌性小鼠進行卵巢器官體外培養,加入300 nmol/L地塞米鬆持續榦預48 h,取2組加入隱丹參酮和麯格列酮榦預48 h,檢測卵巢應用培養液葡萄糖變化情況,利用RT-PCR技術檢測AKT2、CSK3β、ERK、MCN2、CYP17、CYP19、AMH基因錶達水平.採用t檢驗進行統計學分析.結果 地塞米鬆誘導48 h後培養液葡萄糖利用下降,睪酮[分彆為(1.85±0.81)、(0.13±0.12)nmol/L,t=4.21,P=0.006]、雄烯二酮[分彆為(6.44±0.69)、(0.24±0.15)μg/L,t=-5.11,P=0.002]升高,而孕酮[分彆為(14.64±0.68)、(79.38±3.87)nmol/L,t=5.96,P=0.001]、17-羥孕酮[分彆為(0.18±0.09)、(0.44±0.06)μg/L,t=3.408,P=0.014]下降.AKT2、GSK3β、ERK mRNA錶達下調,MCM2、CYP17錶達上調,AMH各組無錶達.隱丹參酮榦預後,處理組葡萄糖利用升高,睪酮[分彆為(0.78±0.23)、(1.85±0.81)nmol/L,t=-2.547,P=0.044]、雄烯二酮[分彆為(4.07±0.50)、(6.44±0.69)μg/L,t=4.019,P=0.009]、孕酮[分彆為(2.97±1.02)、(14.64±0.68)nmol/L,t=5.959,P=0.001]明顯下降,17-羥孕酮[分彆為(0.40±0.08)、(0.18±0.09)μg/L,t=-3.113,P=0.036]升高,信號分子錶達明顯改善.麯格列酮榦預結果與之相似,僅孕酮和17-羥孕酮水平變化相反.結論 地塞米鬆誘導卵巢造成胰島素牴抗,卵巢增殖功能異常,雄激素閤成亢進.隱丹參酮對糖代謝、細胞增殖、激素閤成的信號分子具有調控作用.
목적 통과지새미송체외유도란소기궁이도소저항,탐토은단삼동대당대사、격소이급란소신호분자적영향.방법 40지18 g청길급곤명백자성소서진행란소기관체외배양,가입300 nmol/L지새미송지속간예48 h,취2조가입은단삼동화곡격렬동간예48 h,검측란소응용배양액포도당변화정황,이용RT-PCR기술검측AKT2、CSK3β、ERK、MCN2、CYP17、CYP19、AMH기인표체수평.채용t검험진행통계학분석.결과 지새미송유도48 h후배양액포도당이용하강,고동[분별위(1.85±0.81)、(0.13±0.12)nmol/L,t=4.21,P=0.006]、웅희이동[분별위(6.44±0.69)、(0.24±0.15)μg/L,t=-5.11,P=0.002]승고,이잉동[분별위(14.64±0.68)、(79.38±3.87)nmol/L,t=5.96,P=0.001]、17-간잉동[분별위(0.18±0.09)、(0.44±0.06)μg/L,t=3.408,P=0.014]하강.AKT2、GSK3β、ERK mRNA표체하조,MCM2、CYP17표체상조,AMH각조무표체.은단삼동간예후,처리조포도당이용승고,고동[분별위(0.78±0.23)、(1.85±0.81)nmol/L,t=-2.547,P=0.044]、웅희이동[분별위(4.07±0.50)、(6.44±0.69)μg/L,t=4.019,P=0.009]、잉동[분별위(2.97±1.02)、(14.64±0.68)nmol/L,t=5.959,P=0.001]명현하강,17-간잉동[분별위(0.40±0.08)、(0.18±0.09)μg/L,t=-3.113,P=0.036]승고,신호분자표체명현개선.곡격렬동간예결과여지상사,부잉동화17-간잉동수평변화상반.결론 지새미송유도란소조성이도소저항,란소증식공능이상,웅격소합성항진.은단삼동대당대사、세포증식、격소합성적신호분자구유조공작용.
Objective We hypothesize that cryptotanshinone may directly reduce both insulin resistance and AE of the direct contribution of insulin resistance on ovary induced by dexamethasone. Methods Ovaries from mature mice were isolated and cultured. Insulin resistance was induced in ovaries by dexamethasone (Dex) treatment for 48 h. Insulin-resistant ovaries were further intervened by cryptotanshinone or vericle DMSO in 48 h, and were analyzed with regards to medium glucose, testosterone, androstanedione, progesterone, 17-hydroxide progesterone and estradiol as well as the cellular expression of key signal molecules by RT-PCR. Results Ovaries induced by Dex had a significantly decreased level of glucose utilization, but elevated levels of testosterone and androstanedione as compared with untreated ovaries in medium, indicating establishment of insulin resistance and enhanced androgenic potentials were explored in the induced ovarian. Cryptotanshinone improved glucose utilization in medium, reduced testosterone and androstanedione as compared with vehicle treatment in induced ovaries, suggesting improve significantly insulin resistance and steroidogenesis in induced ovaries. The RT-PCR results showed that dexamethasone decrease the expressions of protein kinase B (AKT2), glycogen synthase kinase-3β (GSK3β) and extracellular regulated protein (ERK), but increased the expressions of cytochrome 17-hydroxylase and minichromosome maitenance protein 2 (MCM2). Cryptotanshinone could improve expression of these signaling molecular mRNA. However, estrogens and its enzymes were reported to be unchanged. Thus, such a differential impacts on theca and granulose by dex will potentiate androgen production in IR ovary. And troglitazone plays similar results as cryptotanshinone except androstanedione, progesterone, 17-hydroxide progesterone. Conclusions Dex could directly induce insulin resistance and androgenic excess within ovaries and crytotanshinon intervene showed beneficial effect. The beneficial effect of cryptotanshinone could ameliorate remarkably molecular regulating proteins of glucose metabolism, cell proliferation and hormone production. This may be a mechanism of Chinese medicine cryptotanshinone improving insulin resistance and androgen synthesis.